medical affairs teams

4.2.2014 Medical Affairs

Making the Most of Scientific Advisory Boards with Clear Objectives

By Jacob Presson, Research Analyst When bringing together a group of active clinicians and specialists for a scientific advisory board, companies should make sure to maximize the effectiveness of the resources seated around the table.  Each person...
 

3.31.2014 Medical Affairs

Looking Outside the Box: How Medical Communications Groups Engage the Medical Community

By Victoria Cavicchi, Research Analyst As the life sciences industry grows, companies’ internal groups must also evolve to match changing demands.  One surveyed pharmaceutical executive explained, “By and large, companies seem to know that...
 

3.28.2014 Medical Affairs

On the Lookout: Pharmaceutical Call Center Outsourcing, Performance Measurement and More!

By Christie Shilling, Research Analyst Medical information teams serve not only as the central hub to which other functions can turn for scientific knowledge, but also as the primary contact center from which HCPs, pharmacists and patients can all...
 

2.11.2014 Medical Affairs

Medical Publications Teams Search for New Performance Metrics

By Christie Shilling, Research Analyst Teams within medical affairs often have substantial trouble gaining management buy-in and, as a result, don’t often receive the resources that they need.  Although most marketing and sales functions can...
 

1.15.2014 Medical Affairs

Medical Affairs Embracing a Patient-Centric 2014

By Nicole May, Research Analyst As pharma moves into 2014, new technologies will allow medical affairs teams to shape their strategies to be increasingly and innovatively patient-centric.  Although a case could be made to stop using the term, whatever...
 

11.18.2013 Medical Affairs

Tips for Medical Affairs Teams Fighting to Eradicate Communicable Diseases

By Jennifer Harrell, Research Analyst While ideological debates and bitter feuds over healthcare reform rage on in America, developing countries suffer from the crippling effects of neglected tropical diseases. Trachoma, for example, is an eye disease...
 

7.26.2013 Medical Affairs

Medical Affairs Team Structure: Centralized or Decentralized?

By Yanis Saradjian, Director of Consulting A medical affairs team’s structure is contingent on a number of determining factors.  The growing complexity of the compliance requirements that pharmaceutical and biotechnology companies must adhere...
 

7.9.2013 Medical Affairs

Global Pharmas in Disagreement about Medical Education Budgets

By Natalie DeMasi, Research Analyst Medical education has been and continues to be a critical segment of a medical affairs team’s mission.  However, the jury is still out in regard to how much time and money a company should devote to it. In...
 

5.29.2013 Health Economics and Outcomes Research (HEOR)

Companies Increasingly Position Health Economics Teams within Medical Affairs

By Yanis Saradjian, Director of Consulting Blockbuster patent expirations are impacting pharmaceutical companies throughout the industry.  Remarkable shifts in corporate earnings send budgetary shock waves through nearly every department of a pharmaceutical...
 

5.7.2013

Regulatory and Compliance Functions Within Medical Affairs Teams

Over the past several years, we have seen a slow shift among regulatory affairs and compliance groups in the pharmaceutical industry as these groups move under medical affairs oversight. This hasn’t been a surprise among many industry observers, but it hasn’t...